Zoetis Inc Class A (ZTS)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

$158.40

Buy

$160.00

arrow-down$-2.42 (-1.50%)

Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Prices updated at 09 May 2025, 10:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.07%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Michael B. McCallister
CEO
Ms. Kristin C. Peck
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
13,800
Head office
10 Sylvan Way
Parsippany
United States
07054
mobile
+1 973 822-7000
letter
steve.frank@zoetis.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Gregory Norden
Independent Director
0.13m--0.37m-
Ms. Louise M. Parent
Independent Director
0.13m--0.37m-
Mr. Michael B. McCallister
Non-Executive Chairman of the Board
0.25m--0.49m-
Mr. Paul M. Bisaro
Independent Director
0.10m--0.34m-
Mr. Robert W. Scully
Independent Director
0.11m--0.35m-
Mr. Wetteny Joseph
Executive Vice President, Principal Accounting Officer and Chief Financial Officer
0.75m--5.09m-
Mr. Frank A. D'Amelio
Independent Director
0.11m--0.36m-
Mr. Sanjay Khosla
Independent Director
0.10m--0.34m-
Ms. Kristin C. Peck
Director and Chief Executive Officer
1.30m--17.21m-
Mr. Gavin D.K. Hattersley
Independent Director
0.08m--0.32m-
Ms. Roxanne Lagano
Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
0.62m--2.62m-
Dr. Willie M. Reed, PhD
Independent Director
0.13m--0.37m-
Ms. Antoinette R. Leatherberry
Independent Director
0.10m--0.34m-
Ms. Julie Fuller
Executive Vice President, Global Operations and Chief Human Resources Officer
-----
Dr. Robert J. Polzer, PhD
Executive Vice President and President, Research and Development
0.66m--2.97m-
Ms. Jeannette Ferran Astorga
Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
-----
Ms. Vanessa Broadhurst
Independent Director
0.10m--0.34m-
Mr. Jamie Brannan
Executive Vice President and Chief Commercial Officer
0.66m--3.02m-
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
-----
Mr. Nick Ashton
Executive Vice President and President, Global Manufacturing and Supply
-----
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital Officer and Chief Technology Officer
-----
Mr. Jared Shriver
President, U.S. Operations
-----
Mr. Mark Stetter
Independent Director
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc41,366,8770.11741201580.29131530 Apr 20259.27
BlackRock Inc38,708,2060.127624764951.24633430 Apr 20258.68
State Street Corp19,842,8460.12754635020.32105230 Apr 20254.45
State Farm Mutual Automobile Ins Co16,011,5102.37611-26093-0.16269930 Apr 20253.59
Vanguard Investments Australia Ltd13,156,9051.23991-68531-30 Apr 20252.95

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
25 Nov 2024-Dr. Robert J. Polzer, PhD160.62169,7754,306--
25 Nov 2024-Dr. Robert J. Polzer, PhD--4,840--
25 Nov 2024-Dr. Robert J. Polzer, PhD--5,455--
25 Nov 2024-Dr. Robert J. Polzer, PhD177.46617,0283,249--
25 Nov 2024-Dr. Robert J. Polzer, PhD162.07392,2096,726--
04 Oct 2024-Mr. Wetteny Joseph61.0710,0773,732--
04 Oct 2024-Ms. Kristin C. Peck61.0717,46651,431--
04 Oct 2024-Ms. Roxanne Lagano61.078,42826,762--
04 Oct 2024-Ms. Wafaa Mamilli61.078,7338,035--
04 Oct 2024-Dr. Robert J. Polzer, PhD61.078,8559,100--
04 Oct 2024-Ms. Jeannette Ferran Astorga61.075,6801,215--
04 Oct 2024-Ms. Rimma Driscoll61.076,0464,459--
04 Oct 2024-Ms. Ester Soria Banque61.079,405320--
03 Sep 2024-Mr. Michael B. McCallister--1--
31 Jul 2024-Ms. Ester Soria Banque180.0455,272588--
31 Jul 2024-Ms. Ester Soria Banque--1,790--
31 Jul 2024-Ms. Ester Soria Banque--895--
12 Jul 2024-Mr. Wetteny Joseph57.538,6303,567--
12 Jul 2024-Ms. Kristin C. Peck57.5314,95851,145--
12 Jul 2024-Ms. Roxanne Lagano57.536,90426,623--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.